Gevo, Inc. (NASDAQ:GEVO - Get Free Report)'s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.21 and traded as high as $1.53. Gevo shares last traded at $1.52, with a volume of 3,919,715 shares changing hands.
Analysts Set New Price Targets
GEVO has been the subject of a number of research analyst reports. UBS Group raised their target price on Gevo from $0.85 to $3.25 and gave the company a "neutral" rating in a research note on Tuesday, October 22nd. HC Wainwright restated a "buy" rating and issued a $14.00 target price on shares of Gevo in a report on Wednesday, November 13th.
Read Our Latest Research Report on Gevo
Gevo Stock Up 3.3 %
The company has a debt-to-equity ratio of 0.13, a quick ratio of 8.05 and a current ratio of 8.25. The company has a market cap of $375.87 million, a PE ratio of -4.62 and a beta of 2.83. The company has a fifty day moving average of $1.94 and a two-hundred day moving average of $1.21.
Insider Transactions at Gevo
In other Gevo news, insider Andrew Shafer sold 26,911 shares of the company's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $2.37, for a total transaction of $63,779.07. Following the completion of the transaction, the insider now directly owns 332,430 shares in the company, valued at approximately $787,859.10. This represents a 7.49 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Paul D. Bloom sold 16,000 shares of the business's stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $3.06, for a total transaction of $48,960.00. Following the sale, the insider now directly owns 947,882 shares of the company's stock, valued at $2,900,518.92. This represents a 1.66 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.00% of the company's stock.
Hedge Funds Weigh In On Gevo
Several hedge funds and other institutional investors have recently made changes to their positions in GEVO. Lauterbach Financial Advisors LLC purchased a new position in Gevo in the 3rd quarter worth approximately $29,000. XTX Topco Ltd lifted its holdings in shares of Gevo by 61.8% in the 2nd quarter. XTX Topco Ltd now owns 133,674 shares of the energy company's stock worth $74,000 after acquiring an additional 51,057 shares during the last quarter. Financial Advocates Investment Management purchased a new position in shares of Gevo during the third quarter worth $114,000. Alternative Investment Advisors LLC. acquired a new position in Gevo in the 2nd quarter valued at about $51,000. Finally, Point72 DIFC Ltd acquired a new stake in Gevo during the 2nd quarter worth approximately $64,000. Hedge funds and other institutional investors own 35.17% of the company's stock.
About Gevo
(
Get Free Report)
Gevo, Inc operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein.
Recommended Stories
Before you consider Gevo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gevo wasn't on the list.
While Gevo currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.